Possible increased risk of rhabdomyolysis during concomitant use of simvastatin and gemfibrozil

EP VanPuijenbroek*, PWG DuBufVereijken, PFMJ Spooren, JJ VanDoormaal

*Corresponding author voor dit werk

Onderzoeksoutput › Academic › peer review

63 Citaten (Scopus)

Vingerafdruk

Duik in de onderzoeksthema's van 'Possible increased risk of rhabdomyolysis during concomitant use of simvastatin and gemfibrozil'. Samen vormen ze een unieke vingerafdruk.

Pharmacology, Toxicology and Pharmaceutical Science

Nursing and Health Professions

Chemistry

Biochemistry, Genetics and Molecular Biology

Keyphrases